Semax

Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro extension. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it has been referenced in published preclinical literature. Manufactured to ≥99% purity with third-party verification.

Semax is a synthetic heptapeptide derived from ACTH(4-10) with a Pro-Gly-Pro stabilizing extension. Developed at the Russian Academy of Sciences, it has been referenced in published preclinical literature. Supplied as a high-purity lyophilized research peptide.

Semax was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in collaboration with Moscow State University. It was designed by modifying the ACTH(4-10) fragment with a Pro-Gly-Pro stabilizing sequence. Published research has referenced this compound since the 1980s.

This peptide carries the True Research Certified designation, awarded exclusively to compounds that achieve verified ≥99% purity through independent third-party HPLC and mass spectrometry analysis. True Research Certified products undergo batch-level endotoxin screening via the LAL (Limulus Amebocyte Lysate) method and are accompanied by a comprehensive Certificate of Analysis (COA) documenting purity, identity, and endotoxin results. This certification reflects our commitment to supplying only the highest-grade research materials to the scientific community.